PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.
| Image |  |
|---|---|
| Description | scientific article published on 12 June 2008 |
| Author/s |
author: Didier Bouscary Jerome Tamburini Nicolas Chapuis Valérie Bardet Norbert Ifrah Zachary A Knight |
| Publication date | June 12, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |